We are live on
!
Find out more
YIH
Y-Intercept (HK) Portfolio holdings
AUM
$5.05B
1-Year Est. Return
17.89%
This Fund
S&P 500
This Quarter
Est. Return
+7.78%
1 Year Est. Return
+17.89%
3 Year Est. Return
+34.37%
5 Year Est. Return
+20.59%
10 Year Est. Return
–
AUM
$1.63B
AUM Growth
-$190M
(-10%)
Cap. Flow
-$267M
Cap. Flow
% of AUM
-16.34%
Top 10 Holdings %
Top 10 Hldgs %
11.15%
Holding
1,936
New
615
Increased
263
Reduced
359
Closed
699
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$33.7M |
| 2 |
Microsoft
MSFT
|
+$31.5M |
| 3 |
Eli Lilly
LLY
|
+$14.3M |
| 4 |
JD.com
JD
|
+$13.5M |
| 5 |
Vale
VALE
|
+$12.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Super Micro Computer
SMCI
|
+$39.3M |
| 2 |
Broadcom
AVGO
|
+$24.8M |
| 3 |
Apple
AAPL
|
+$22M |
| 4 |
ConocoPhillips
COP
|
+$18M |
| 5 |
Nu Holdings
NU
|
+$13.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.96% |
| 2 | Healthcare | 13.76% |
| 3 | Financials | 12.65% |
| 4 | Consumer Discretionary | 12.5% |
| 5 | Industrials | 11.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIVK
1226
Vivakor
VIVK
$1.27M
| $47.6K | ﹤0.01% |
+8
| New | +$64.8K |
|
1227
Editas Medicine
EDIT
$399M
| $46.6K | ﹤0.01% |
+13,662
| New | +$59.5K |
|
1228
Zentalis Pharmaceuticals
ZNTL
$329M
| $45.3K | ﹤0.01% |
12,303
-91,613
| -88% | -$333K |
|
1229
IZEA Worldwide
IZEA
$59.7M
| $40.4K | ﹤0.01% |
+14,688
| New | +$34.3K |
|
1230
Heron Therapeutics
HRTX
$93.8M
| $39.1K | ﹤0.01% |
+19,629
| New | +$46.9K |
|
1231
Nautilus Biotechnolgy
NAUT
$151M
| $35.4K | ﹤0.01% |
12,404
-11,512
| -48% | -$29.8K |
|
|
AXDX
1232
DELISTED
Accelerate Diagnostics
AXDX
| $34K | ﹤0.01% |
+19,866
| New | +$29.4K |
|
|
CMLS
1233
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $25.2K | ﹤0.01% |
+19,272
| New | +$33K |
|
1234
Research Frontiers
REFR
$15.3M
| $24K | ﹤0.01% |
+10,965
| New | +$22.7K |
|
1235
Great Elm Group
GEG
$67.4M
| $22.4K | ﹤0.01% |
+11,738
| New | +$21.4K |
|
|
CTV
1236
DELISTED
Innovid Corp.
CTV
| $18.7K | ﹤0.01% |
10,396
-6,642
| -39% | -$12.1K |
|
|
LNAI
1237
Lunai Bioworks
LNAI
$10.2M
| $5.98K | ﹤0.01% |
+155
| New | +$10.7K |
|
1238
Alcoa
AA
$11.7B
| – | – |
-18,239
| Closed | -$726K |
|
|
1239
Apple
AAPL
$4.97T
| – | – |
-104,448
| Closed | -$22M |
|
1240
AbbVie
ABBV
$470B
| – | – |
-12,505
| Closed | -$2.14M |
|
1241
ABM Industries
ABM
$2.87B
| – | – |
-19,712
| Closed | -$997K |
|
1242
Adicet Bio
ACET
$74.2M
| – | – |
-11,957
| Closed | -$231K |
|
1243
Aecom
ACM
$9.67B
| – | – |
-24,600
| Closed | -$2.17M |
|
1244
Aclaris Therapeutics
ACRS
$740M
| – | – |
-114,806
| Closed | -$126K |
|
1245
Enact Holdings
ACT
$6.7B
| – | – |
-36,450
| Closed | -$1.12M |
|
1246
iShares MSCI ACWI ETF
ACWI
$32.5B
| – | – |
-5,400
| Closed | -$607K |
|
1247
Analog Devices
ADI
$179B
| – | – |
-11,688
| Closed | -$2.67M |
|
1248
Archer Daniels Midland
ADM
$39.9B
| – | – |
-70,478
| Closed | -$4.26M |
|
1249
ADMA Biologics
ADMA
$2.02B
| – | – |
-34,055
| Closed | -$381K |
|
1250
Adient
ADNT
$1.68B
| – | – |
-35,562
| Closed | -$879K |
|
Similar funds
HSA
O
LIM
LFG
JIM
CTC
NL
BPWM
Y-Intercept (HK)'s Q3 2024 Portfolio in Review
As of Q3 2024, Y-Intercept (HK) held 1,936 positions worth $1.63B, down 10% from $1.82B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Y-Intercept (HK) withdrew a net $267M in Q3 2024, closing 699 positions and reducing 359 holdings. Its most notable exit was Super Micro Computer, an estimated $39.3M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Y-Intercept (HK) opened a new position in NVIDIA worth $34.6M.
- Y-Intercept (HK)'s largest Q3 2024 buy was NVIDIA: 285,153 shares worth $34.6M.
- Y-Intercept (HK) added most to CVS Health in Q3 2024, an estimated $8.52M increase.
- Y-Intercept (HK)'s biggest Q3 2024 reduction was ExxonMobil, cutting an estimated $12.8M.
- Y-Intercept (HK) fully exited Super Micro Computer in Q3 2024, selling an estimated $39.3M.
- Y-Intercept (HK)'s ten largest holdings make up 11% of its $1.63B portfolio in Q3 2024.
- Y-Intercept (HK) opened 615 new positions and closed 699 in Q3 2024.
- Y-Intercept (HK)'s portfolio value fell 10% quarter-over-quarter to $1.63B.
Based on Y-Intercept (HK)'s 13F filing for Q3 2024, filed 15 Nov 2024.